Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Mankind Pharma enters into agri-tech segment with launch of Mankind Agritech

Ruchika Sharma5 April 2022 11:48 AM IST

The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment...

Sanofi Dupixent under USFDA priority review for eosinophilic esophagitis patients

Ruchika Sharma5 April 2022 11:30 AM IST

Paris: Sanofi has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the supplemental Biologics...

Dr Reddys, MediCane Health introduce medical cannabis products in Germany

Ruchika Sharma5 April 2022 11:00 AM IST

For Dr Reddy's, the launch reinforces its presence in Germany's growing medical cannabis market.

GST for COVID drugs pegged at 5 percent, says Govt

Ruchika Sharma5 April 2022 10:30 AM IST

New Delhi: COVID-19 medicines and instruments are being sold at a GST rate of five per cent while other medicines are sold at a GST rate between five...

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer Thrombosis drug Asundexian shows positive study result

Ruchika Sharma5 April 2022 10:00 AM IST

Asundexian is a so-called factor 11a inhibitor and was being compared to a drug sold under the brand name Eliquis by Pfizer and Bristol-Myers Squibb...

DGHS pauses choice filling for NEET SS after doctors flag issue

Ruchika Sharma4 April 2022 5:50 PM IST

Taking note of the fact that more than 250 super specialty seats of medical colleges had not been included earlier to the seat matrix, the Medical...

Trade margin on medical devices capped to end menace of exaggerated MRP, says Divisional Commissioner Kashmir

Ruchika Sharma4 April 2022 3:34 PM IST

Srinagar: The Divisional Commissioner Kashmir, Pandurang K Pole on Sunday said that the administration has achieved a major breakthrough in keeping...

Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer

Roche gets USFDA priority review for Actemra to treat Covid-19

Ruchika Sharma4 April 2022 2:32 PM IST

Basel: Roche today announced that the U.S. Food and Drug Administration (USFDA) has accepted the company's supplemental Biologics License Application...

No impact on Covaxin safety, clarifies Bharat Biotech after WHO suspension

Ruchika Sharma4 April 2022 1:06 PM IST

"It does not indicate a change in risk-benefit ratio (for Covaxin) and the data, available to WHO, indicates the vaccine is effective and no safety...

WIPRO GE Healthcare MD Dr Shravan Subramanyam appointed as NATHEALTH new President

Ruchika Sharma4 April 2022 12:33 PM IST

New Delhi: Dr. Shravan Subramanyam, Managing Director, Wipro GE Healthcare Pvt. Ltd has been announced as the President of NATHEALTH – an apex...

Govt panel recommends SII Covovax inclusion in national vaccination programme for 12 and above

Ruchika Sharma4 April 2022 12:06 PM IST

Singh had stated that the Pune-based firm wanted to provide Covovax to private hospitals at Rs 900 per dose plus GST and was waiting for directions to...

JBCPL gets trademark assignment of HF drug Azmarda from Novartis for Rs 246 crores

Ruchika Sharma4 April 2022 11:22 AM IST

Mumbai: JB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok